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Abstract
In this multicenter, prospective study of 288 children (half under 2 years of age) undergoing
cardiac surgery, we evaluated whether the measurement of pre- and postoperative serum cystatin
C (CysC) improves the prediction of acute kidney injury (AKI) over that obtained by serum
creatinine (SCr). Higher preoperative SCr-based estimated glomerular filtration rates predicted
higher risk of the postoperative primary outcomes of stage 1 and 2 AKI (adjusted odds ratios
(ORs) 1.5 and 1.9, respectively). Preoperative CysC was not associated with AKI. The highest
quintile of postoperative (within 6 h) CysC predicted stage 1 and 2 AKI (adjusted ORs of 6 and
17.2, respectively). The highest tertile of percent change in CysC independently predicted AKI,
whereas the highest tertile of SCr predicted stage 1 but not stage 2 AKI. Postoperative CysC levels
independently predicted longer duration of ventilation and intensive care unit length of stay,
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whereas the postoperative SCr change only predicted longer intensive care unit stay. Thus,
postoperative serum CysC is useful to risk-stratify patients for AKI treatment trials. More
research, however, is needed to understand the relation between preoperative renal function and
the risk of AKI.
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The development of acute kidney injury (AKI) is a risk factor for negative hospital
outcomes in adults and children who undergo cardiac surgery.1–3 Intense contemporary
research has been directed toward validating novel biomarkers to predict AKI earlier than is
feasible with acute changes in serum creatinine (SCr).4–7 This is with the ultimate goal
being to initiate potential AKI treatments in clinical trials and in clinical practice
eventually.8 Currently, early AKI diagnosis may direct clinicians to apply timely
conservative treatments such as avoidance of nephrotoxins and optimization of fluid status.
Early AKI diagnosis is an especially challenging task in children. In a previous single-centre
retrospective study, we found that a substantial proportion of children display signs of AKI
defined by acute SCr rise within hours after cardiac surgery and that most AKI occurs within
the first 2–3 postoperative days.3 Therefore, preoperative and early postoperative clinical
data and biological markers will offer the highest chance of capturing patients who will
develop AKI or who are in the early stages of AKI. Some studies suggest that the presence
of chronic kidney disease (CKD) is a risk factor for developing AKI in different
settings,1,9,10 although this remains inconclusive in adults11,12 and has not been well studied
in children.
Serum cystatin C (CysC) is a more accurate marker of glomerular filtration rate (GFR) than
SCr in children with CKD.13,14 The benefit of using serum CysC for early AKI diagnosis in
critically ill patients has been controversial.15 Because CysC is a marker of filtration, it is
unclear whether it should be expressed as a percentage change from baseline levels, when
measured postoperatively for AKI prediction (like SCr is), or whether raw concentration
values should be used. In terms of preoperative AKI risk prediction in children, SCr
concentrations are highly affected by multiple non-renal factors, including gender, age,
growth, and muscle mass.14 Therefore CysC may offer a novel method for AKI risk
stratification before cardiac surgery.
In this multicenter, prospective study of children undergoing cardiac surgery, we sought to
compare the abilities of (1) preoperative SCr and CysC, and of (2) first postoperative serum
CysC and SCr to predict cardiac surgery-associated AKI as well as secondary outcomes
including length of stay and duration of mechanical ventilation. Because of lack of previous
literature on CysC, we also evaluated different methods of expressing postoperative CysC
for evaluating the ability of CysC to predict AKI.
RESULTS
Study population
Among 311 children in this study, 288 were available for analysis, after excluding subjects
with missing biomarker data. Table 1 displays the baseline and outcome characteristics of
the study cohort. Half the cohort was less than 2 years old and most subjects had normal
preoperative estimated GFR (eGFR), with 27 subjects (9%) having preoperative eGFR
below the 10th percentile of normative age-adjusted values (Figure 1). In all, 42% of the
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(n=288) cohort developed stage 1 AKI or worse (≥50% or 26.5 μmol/l SCr rise above
baseline or need for dialysis) and 11% developed stage 2 AKI or worse (doubling of SCr or
need for dialysis). All children who had a 26.5 mmol/l rise in SCr also had a ≥50% SCr rise
and all patients who had a ≥50% SCr rise also had a 26.5 μmol/l rise in SCr from baseline.
Four of the five subjects requiring dialysis had a ≥50% SCr rise from baseline at the time of
dialysis initiation.
Predicting AKI from preoperative renal function with serum creatinine and serum cystatin
C
Table 2 displays the characteristics of different preoperative renal function measures for
predicting postoperative stage 1 and 2 AKI in all subjects (expressed as odds ratios (OR) and
area under the receiver operating characteristic curves (AUC)). In the whole cohort, stage 1
AKI or worse occurred on average 36±14 h and stage 2 AKI or worse occurred 41±12 h
after the end of surgery. In unadjusted analyses, higher preoperative CysC predicted
postoperative stage 1 and 2 AKI, but this association disappeared in adjusted analyses. There
was no significant increase in AUC when CysC was added to the regression model to predict
stage 1 or 2 AKI, compared with clinical variables alone (lower portion of Table 2). Pre-
operative eGFR in ml/min per 1.73 m2 and in percentile value was significantly associated
with development of postoperative stage 1 and 2 AKI in adjusted analyses (Table 2). There
was a modest and statistically significant increase in AUC when preoperative eGFR was
added to the predictive model, compared with using clinical variables alone (~5% AUC
increase, P<0.05), Of note, the association between eGFR and AKI development was
positive, indicating that higher preoperative eGFR was associated with an increased risk of
AKI development.
Comparison of first postoperative biomarkers (serum creatinine and cystatin C) to predict
AKI
Table 3 displays the ability of first postoperative CysC and SCr to predict stage 1 or 2 AKI
in patients who did not already have these events (n=241 and n=267, respectively) within
the 6 h after the end of surgery. In these subjects, stage 1 AKI occurred on average 43±12 h
and stage 2 AKI occurred 48±7 h after surgery. First postoperative CysC concentration in
the 5th quintile (1.01–2.91 mg/l) was independently associated with development of stage 1
AKI and of stage 2 AKI (shown in the upper portion of Table 3). First postoperative CysC
≥1.16 mg/l (the cutoff derived from a previously performed study),16 was also associated
with future stage 1 AKI development (adjusted OR=6.4, 95% confidence interval (CI)=1.9–
22.3) and stage 2 AKI (adjusted OR=20.0, 95% CI=4.1–97.5). When CysC was expressed as
percent change from preoperative value, the highest tertile of percent CysC change was
independently associated with development of stage 1 and 2 AKI (Table 3). Adding CysC
concentration to the model to predict AKI including clinical variables alone resulted in an
increase in AUC of 7% for predicting stage 1 AKI (P<0.01 for increase in AUC) and an
~5% increase in AUC for predicting stage 2 AKI (P=0.09).
First postoperative percent SCr change was also independently associated with the
development of stage 1 AKI, but not of stage 2 AKI (Table 3). When percent SCr change
was added to the clinical variable predictive model, AUC increased by ~5% for predicting
future stage 1 AKI (P<0.01), but by only ~2% for predicting stage 2 AKI (P=0.2). When
time after surgery (hours) of first postoperative blood sample was controlled for in all
analyses, ORs were nearly identical except confidence intervals (CIs) were wider.
Predicting length of stay and duration of mechanical ventilation
The associations between first postoperative CysC value (mg/dl), percent CysC change from
baseline and percent SCr change from baseline and length of hospital or intensive care unit
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stay and duration of mechanical ventilation, were evaluated. In all, 288 (72%) of children
were still mechanically ventilated at the time of first postoperative CysC and SCr
measurement. Figure 2 displays that there was a statistically significant association between
increasing first postoperative CysC value and longer duration of mechanical ventilation, in
univariate analyses (P<0.001, Jonckheere-Terpstra test).
In multiple linear regression analyses, adjusting for clinical factors, only first postoperative
percent CysC change from baseline (P = 0.04) and first postoperative CysC value
(P<0.001), but not percent SCr change from baseline, were independently associated with
longer duration of mechanical ventilation. Only first postoperative CysC value was
independently associated with longer length of hospital stay (P = 0.04). First postoperative
percent SCr change from baseline (P = 0.02) and first postoperative CysC value (P = 0.002),
but not percent CysC change from baseline, were associated with longer length of intensive
care unit stay.
DISCUSSION
In this multicenter study of children undergoing cardiac surgery, higher CysC concentrations
obtained within the first 6 h of surgery strongly predicted stage 2 (more severe) AKI
development in the subsequent days, as well as longer duration of mechanical ventilation
and longer length of stay. We found that preoperative CysC did not predict the development
of postoperative AKI. However, higher pre-operative eGFR and percent SCr change in the
first 6 h after surgery predicted the development of postoperative stage 1 (or mild) AKI.
This is the first study to directly compare two markers of GFR, SCr and CysC, for early
prediction of AKI in children.
Preoperative CysC concentrations were not associated with development of postoperative
AKI, when adjusted for other clinical factors, such as cardiopulmonary bypass time,
demographics, and surgical severity score. Interestingly, we found that higher and not lower
preoperative eGFR was associated with the development of AKI, even when we
meticulously adjusted for age-associated differences in GFR by deriving GFR percentile
values and adjusting for age in multivariate analyses. These two findings appear to refute
our underlying hypothesis that preoperative CKD is a risk factor for AKI, as has been
suggested by adult studies11 and in one study of AKI in children treated with
aminoglycosides.17 A potential explanation is that children who are malnourished with
lower muscle mass and consequently lower SCr concentrations (resulting in higher eGFR),
are at increased risk for AKI development. This highlights the limitations of using SCr for
GFR estimations. However, it is also possible that because few subjects had preoperative
CKD, we may not have been able to detect a CKD–AKI association. Another possible
confounding factor is that the Schwartz formula, which was derived from children greater
than 2 years of age with established CKD,18 overestimates GFR, particularly in infants or
children with fairly preserved renal function. This is supported by the fact that the median
preoperative eGFR percentile value for children under 2 years old was the 81st percentile,
compared with the 41st percentile in older children (shown in Figure 1, for children less than
2 years old), suggesting that eGFR is overestimated in younger children. We did not
estimate GFR using published CysC equations, as none of them have been validated in
infants. These results provide a serendipitous indicator that future studies should attempt to
derive equations from SCr and CysC specific to younger children, as well as to children with
GFR approaching the normal range, which may help better identify mild CKD as a risk
factor for postoperative AKI. Finally, it is possible that the use of a SCr-based AKI
definition is an imperfect, yet only available, reference standard, which is currently a
challenge for all AKI studies.
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From our previous work, we discovered that almost all postoperative cardiac surgery-
associated AKI occurs within the first 3 days after surgery.3 Therefore, AKI therapeutic
trials in this population will need to provide an intervention as early as possible during or
after surgery. We found that postoperative serum CysC concentrations in the 5th quintile
(>1.01 mg/dl), obtained very early after surgery, independently predicted development of
stage 2 AKI. The cut-point of 1.16 mg/dl from a recent single-centre study was strongly
associated with AKI severity.16 Thus, early postoperative CysC may be helpful for future
clinical trials aimed at reducing the incidence of SCr doubling and dialysis need or other
clinical outcomes such as duration of ventilation. We also found that clinical variables that
are easily determinable immediately after surgery provided fairly good prediction of
postoperative AKI development. It is likely that using a combination of clinical and early
postoperative biomarker data will provide the best method for determining eligibility into
future AKI clinical trials in children undergoing cardiac surgery, to optimize sensitivity and
specificity.
Although we have demonstrated that CysC may have a role in early stage 2 AKI
identification for trials, it is still unclear to what extent CysC should be used in clinical care.
CysC currently costs significantly more to measure than SCr does, though cost will
hopefully become less of a hindrance in time. Second, as we currently do not have specific
treatments for AKI in children, whether or not incorporating CysC into clinical care will
improve outcome will remain unknown until trials are performed. Therefore, we propose
that future AKI clinical trials should incorporate measurement of CysC and cost analyses as
outcomes. Trials examining currently available measures of managing AKI (such as early
dialysis initiation or early goal-directed fluid management) should examine if knowledge of
early postoperative CysC concentrations would lead to changes in outcomes such as
duration of mechanical ventilation or management of fluid balance and oxygenation. The
results of our study justify thorough evaluations of incorporating CysC into clinical care of
this population.
Our study had several unique strengths. This is the first multicenter study of AKI and new
AKI biomarkers in children, and to our knowledge the first study to examine specifically the
role of preoperative renal function for AKI prediction in children. Because the timing of the
most likely renal injurious event was known (cardiopulmonary bypass surgery), we were
able to identify a clinically reproducible time point on which to evaluate CysC for early AKI
prediction. Our use of eGFR percentiles for expressing preoperative renal function is novel
and likely more valid for expressing renal function in younger children who are known to
have an expected age- and development-associated lower raw eGFR value compared with
older children. Another strength was our careful exclusion of subjects who already had clear
evidence of AKI immediately postoperatively, when evaluating the ability of CysC to truly
predict AKI earlier than SCr can. We evaluated doubling of SCr or need for dialysis (stage 2
AKI) as one of our primary outcomes. Thus, our findings will be useful for future clinical
trials for AKI, which are likely to use a similar clinically meaningful outcome.
A limitation of this study was the somewhat restricted sample size, which did not allow us to
adequately evaluate for effect modification and led to poor precision around some estimates,
with wide CIs. Although the low prevalence of significant preoperative CKD was a
limitation in being able to assess the CKD–AKI relation, our finding that few children
having complex heart surgery have baseline CKD was important to demonstrate for future
studies and understanding this population. Our study was limited to children undergoing
cardiac surgery; therefore, the findings may not be immediately generalizable to all other
hospitalized children and similarly rigorous studies in other non-cardiac pediatric
populations are warranted.
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In conclusion, the use of clinical risk factors may have an important role in predicting
postoperative AKI in children who have had cardiac surgery. Early postoperative CysC is a
useful marker to predict development of AKI but preoperative CysC does not contribute
significantly. More research is required to better understand how to estimate preoperative
renal function in young children and in children with GFR in the normal to mildly low
range.
MATERIALS AND METHODS
Study design and study population
The Translational Research Investigating Biomarker Endpoints in AKI (TRIBE-AKI) study
was a prospective USA–Canada, multi-center cohort study of patients undergoing cardiac
surgery, with the objective to validate biomarkers of AKI. Three pediatric centers were
included: Cincinnati Children's Hospital Medical Center (Cincinnati), Yale Children's
Hospital (Yale), and Montreal Children's Hospital (Montreal). All children undergoing
cardio-pulmonary bypass surgery for congenital cardiac surgery repairs were eligible.
Patients with end stage renal disease or overt preoperative AKI (known SCr increase of
≥44.2 μmol/l from baseline before surgery) were excluded. For this analysis, we excluded
subjects who were less than 1-month-old (due to challenges and controversies in defining
AKI in the neonatal population19). We also excluded patients who did not have preoperative
SCr, CysC, and height as well as postoperative SCr and CysC available. All centers obtained
institutional internal review or research ethics board approval before study initiation and
parental informed consent was obtained from all subjects.
Study procedure
Procedure aspects pertinent to this study are reported. Subjects were recruited preoperatively
within 1 month of surgery. Blood samples were obtained during routine phlebotomy at the
time of preoperative evaluation or on anesthesia induction, for SCr and CysC measurement.
On admission to the intensive care unit, additional blood was drawn for CysC measurement
within 6 h of surgery and was concurrent with the first planned routine blood testing. SCr
was measured routinely by the treating team, from shortly after surgery (at the same time as
the first postoperative CysC measurement) and every morning thereafter during intensive
care unit and hospital stay. Blood for CysC measurement was centrifuged and the plasma
aliquoted for storage at −80 °C until shipped for measurement. Each individual subject had
pre- and postoperative SCr measured using the same SCr assay at the same laboratory. CysC
was measured using a nephelo-meter (Siemens BN-II, Siemens, AG; www.Siemens.com) at
the Cincinnati Children's Hospital Biomarker Laboratory (coefficient of variation=1.1%).
Individuals performing the SCr and CysC assays were blinded to the clinical data.
Clinical data collection
The following clinical variables were collected: age, gender, study site, cardiopulmonary
bypass time, and the Risk Adjustment in Congenital Heart Surgery (RACHS-1) score.20
RACHS-1 contains six categories designed to differentiate surgical risk for mortality on the
basis of procedure. Height was recorded to calculate preoperative eGFR.
Pre-operative renal function assessment
One of our objectives was to evaluate the ability of preoperative renal function to predict
postoperative AKI. Pre-operative renal function was assessed by preoperative CysC and SCr
concentrations. Pre-operative CysC was expressed as actual concentration values (mg/dl).
Pre-operative SCr was expressed as estimated GFR (eGFR, by the Schwartz formula
36.5×height in cm/SCr in μmol/l),18 because of the dependence of SCr concentrations on
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muscle mass. We noted a methodological challenge of eGFR interpretation in younger
children. Children less than 2 years old have a physiologically lower GFR than older
children,21 making it difficult to use raw eGFR as a risk factor of AKI when studying
children aged 1 month to 18 years old. One previous study of children with normal renal
function from ages 0.1 to 19 years old reported measurement of nuclear medicine scan GFR
in 651 individuals.22 We generated percentile value GFR norms according to age, using the
data provided by the corresponding author. We plotted our subjects' preoperative eGFR
percentiles using these normative values (shown in Figure 1). To understand how the
utilization of raw versus percentile preoperative eGFR values affected our results, we
analyzed both methods of preoperative eGFR expression (eGFR in ml/min per 1.73 m2 and
eGFR percentile value).
First postoperative SCr and CysC evaluation
Our goal was to provide a comparison of the ability of first postoperative SCr versus first
postoperative CysC concentrations to predict development of the AKI outcomes, to
elucidate to what extent utilizing CysC would lead to improved AKI prediction over the
current standard biomarker, SCr. We expressed the first postoperative SCr value as a
percentage change from preoperative concentrations (first postoperative SCr/preoperative
SCr×100). Because there was little prior research on use and interpretation of CysC in the
intensive care unit, we expressed the first postoperative CysC concentrations in 2 ways: (1)
as raw first postoperative CysC concentration (mg/dl) and (2) as a percentage change from
preoperative concentrations, similar to how SCr was expressed (first postoperative CysC/
preoperative CysC×100). We also evaluated the presence of first postoperative CysC value
of < versus ≥1.16 mg/dl, based on a significant postoperative CysC cutoff found to be
predictive of postoperative cardiac surgery-associated AKI, in a previously published single-
centre pediatric study.16
Definition of AKI
AKI was defined according to the Acute Kidney Injury Network (AKIN) staging.23 We
evaluated two primary postoperative AKI outcomes: (1) `mild AKI' or stage 1 AKI
according to the AKIN staging (≥50% SCr rise from baseline or a 26.5 mmol/l SCr rise
from baseline or need for dialysis) and (2) `severe AKI' or stage 2 AKI according to the
AKIN staging (doubling of SCr from baseline or need for dialysis).
Other outcomes
We evaluated length of intensive care unit and hospital stay and duration (days) of
mechanical ventilation as secondary outcomes. There were only four deaths, therefore we
could not evaluate mortality as an outcome.
Statistical analysis
Continuous variables were expressed as mean±standard deviation and categorical variables
as proportions (n, %). To calculate preoperative eGFR percentiles a quantile regression
model using intercept and log-transformed age, in children < and ≥2 years old, was fitted
using data from the normal renal function pediatric patient study by Piepsz et al.22 The proc
quantreg procedure of the SAS 9.2 statistical software (Cary, NC) was used for this analysis.
To evaluate the association between preoperative renal function (preoperative CysC, eGFR,
and eGFR percentile) and postoperative stage 1 AKI or stage 2 AKI, multiple logistic
regression was used, controlling for age (< or ≥2 years old), gender, RACHS-1 score (1 or 2
versus 3 versus 4), study site (as a fixed effect), and cardiopulmonary bypass time (≤60, 61–
90, 91–120, 121–180, or ≥181 min). For these analyses, preoperative CysC, eGFR, and
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eGFR percentile were expressed in the logarithmic scale to allow for similar scaling between
all three measures and to account for skewed distribution. For pre-op eGFR percentile, we
added 1 to all values before logarithmic transformation as some percentile values were at or
near zero.
To evaluate the association between first postoperative percent SCr change from baseline,
percent CysC change from baseline or first postoperative CysC value and development of
stage 1 or 2 AKI, we used multiple logistic regression, controlling for age (< or ≥2 years
old), gender, RACHS-1 score (1 or 2 versus 3 versus 4), study site (as a fixed effect),
cardiopulmonary bypass time (≤60, 61–90, 91–120, 121–180, or ≥181 min), as well as
preoperative eGFR percentile. We also evaluated whether the time (hours) of first
postoperative blood sampling affected results. For these analyses, we expressed first
postoperative percent SCr change and percent CysC change from baseline into tertile
categories and first postoperative CysC values into quintile categories to adjust for non-
normal distribution of these values and also to enhance interpretation of the derived ORs. Of
note, we only included subjects in these analyses who did not already have the AKI event on
the first postoperative blood sampling to avoid overestimating the predictive association of
CysC and already-diagnosable AKI. AUC for first postoperative percent SCr and CysC
change from baseline and for first postoperative CysC value to predict stage 1 or 2 AKI was
also calculated. All AUC's and OR's were expressed as point estimates and associated 95%
CI. Differences in calculated AUC's were tested for significance using the test developed by
DeLong et al.24
To evaluate the association between first postoperative SCr and CysC to predict length of
stay and duration of mechanical ventilation, multiple linear regression was used, controlling
for age (< or ≥2 years old), gender, RACHS-1 score (1 or 2 versus 3 versus 4), study site,
cardiopulmonary bypass time (≤60, 61–90, 91–120, 121–180, or ≥181 min), preoperative
eGFR percentile, and postoperative time (hours) of first postoperative blood sampling.
Because of non-normal distribution of length of stay and of duration of mechanical
ventilation, we log-transformed these variables for inclusion in regression analyses.
Statistical software R version 2.10.1 and SAS 9.2 statistical software were used to perform
all analyses.
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Figure 1. Plotted glomerular filtration rate (GFR) percentile values for subjects less than 2 years
old
Displays the percentile curves for GFR derived from normal children from infancy to young
adulthood. Individual preoperative estimated GFR (eGFR) of subjects from this study are
plotted on the curves (+). To the right of the graph, the value for each percentile (Pct) curve
shown.
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Figure 2. Association of postoperative serum creatinine (SCr) and cystatin C (CysC) with
duration of ventilation
Displays mean duration of mechanical ventilation (days) for the (a) quintiles of first
postoperative CysC concentrations, (b) tertiles of first postoperative percent CystC change
and (c) tertiles of first postoperative percent SCr change from baseline. Standard errors were
extremely low (ranging from 0.01 to 0.04, and are not displayed). Univariate P-values for
test of linear trend are displayed.
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Table 1
Characteristics and outcomes of the study cohort (n=288)
Categorical variables: n (%) Continuous variables: mean±s.d., median
[interquartile range]
Male gender 159 (55%)
Age (years) 3.8±4.5, 2.1 [5.0]
≤2 Years old 144 (50%)
Height/length (cm) 90±33, 81 [46.5]
 Percentile 32±32, 20 [58]
 Standard deviation score −0.9±2.2, −0.8 [2.2]
Weight (kg) 16.4±17.3, 10.5 [12.6]
 Percentile 29±33, 12 [54]
 Standard deviation score −1.1±2.0, −1.2 [2.4]
Study site
 Cincinnati, Ohio 197 (68%)
 Montreal, Quebec 57 (20%)
 New Haven, Connecticut 34 (12%)
Operative characteristics
 RACHS-1 score ≥3a 129 (45%)
 Cardiopulmonary bypass timeb
  <60 min 54 (19%)
  61–90 min 80 (28%)
  91–120 min 60 (21%)
  121–180 min 65 (23%)
  >180 min 29 (10%)
Renal function
 Preoperative CysC (mg/dl) 0.8±0.2, 0.73 [0.29]
 Preoperative estimated GFR (ml/min per 1.73 m2)c 90.5±25.4, 87.8 [31.6]
 Preoperative estimated GFR percentilec 52.7±34, 56 [66]
First postoperative markers
 Hours after surgery of 1st postoperative blood sampling 0.6±1.3, 0.5 [0.33]
 Cys C (mg/l) 0.77±0.32, 0.69 [0.38]
 % SCr change from baseline 15±20, 16 [33]
 % CysC change from baseline −1±27, −7 [29]
AKI and other outcomes
 Stage 1 AKId 121 (42%)
 Stage 2 AKId 47 (11%)
 Dialysis 5 (2%)
 Length of intensive care unit stay (days) 4.0±6.1, 2.0 [3.0]
 Length of hospital stay (days) 8.0±9.2, 5.0 [4.0]
 Duration of mechanical ventilation (days) 1.4±1.5, 1.0 [2.0]
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Categorical variables: n (%) Continuous variables: mean±s.d., median
[interquartile range]
 Mortality 4 (1.4%)
Abbreviations: AKI, acute kidney injury; CysC, cystatin C; GFR, glomerular filtration rate; SCr, serum creatinine.
a
Risk Adjustment in Congenital Heart Surgery (RACHS)-1 score.
b
Four subjects who did not receive cardiopulmonary bypass were not included in these descriptive analyses.
c
Estimated GFR (glomerular filtration) was calculated by the Schwartz formula.18 For percentile estimated GFR, normative values from children
with normal renal function was used for percentile derivation.22
d
Stage 1 AKI: ≥50% or 26.5 μmol/l SCr rise from baseline or need for dialysis; stage 2 AKI: ≥doubling of SCr from baseline or need for dialysis.
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Table 2
Comparison of preoperative CysC and preoperative eGFR as predictors of postoperative stage 1 and stage 2
AKI
Stage 1 AKI (#events=121) Stage 2 AKI (#events=47)
Association of preoperative renal function with AKIa
Unadjusted OR (95%
CI)
Adjusted OR (95%
CI)b
Unadjusted OR (95%
CI)
Adjusted OR (95%
CI)b
Pre-operative CysC (mg/l) 5.2 (2.2, 12.2) 1.4 (0.5, 4.4) 5.5 (1.9, 16.2) 2.1 (0.5, 9.0)
Pre-operative eGFR (ml/min per
1.73 m2) 1.2 (0.5, 2.6) 8.4 (2.7, 25.9) 2.9 (0.9, 9.0) 34.9 (7, 174.3)
Pre-operative eGFR percentile 1.3 (1.1, 1.7) 1.5 (1.2, 2.0) 1.6 (1.1, 2.3) 1.9 (1.2, 3.0)
Area under receiver operating characteristic curvea
Unadjusted AUC
(95% CI)
Adjusted AUC (95%
CI)b
Unadjusted AUC
(95% CI)
Adjusted AUC (95%
C)b
Clinical variables onlyc NA 0.73 (0.67, 0.80) NA 0.79 (0.70, 0.87)
Pre-operative CysC (mg/l) 0.63 (0.57, 0.70) 0.74 (0.68, 0.80) 0.62 (0.53, 0.72) 0.79 (0.70, 0.87)
Pre-operative eGFR (ml/min per
1.73 m2) 0.51 (0.44, 0.58) 0.77 (0.71, 0.82)d 0.59 (0.50, 0.68) 0.84 (0.77, 0.92)d
Pre-operative eGFR percentile 0.66 (0.59, 0.72) 0.76 (0.70, 0.82)d 0.68 (0.60, 0.77) 0.82 (0.74, 0.90)d
Abbreviations: AKI, acute kidney injury; AUC, area under the curve; CI, confidence interval; CysC, cystatin C; eGFR, estimated GFR; GFR,
glomerular filtration rate; NA, not applicable; OR, odds ratio.
a
Note: preoperative CysC, eGFR, and eGFR percentile were transformed to their logarithm for inclusion in logistic regression analyses.
b
Adjusted for age, gender, Risk Adjustment in Congenital Heart Surgery (RACHS)-1 score, cardiopulmonary bypass time, and study site.
c
This model includes only clinical variables (age, gender, RACHS-1 score, cardiopulmonary bypass time, and study site), to determine how
accurately AKI may be predicted without the use of biomarkers.
d
Adding preoperative eGFR to the clinical model led to a significant increase in AUC (P<0.05), compared with clinical variables alone.
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